Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1743929
Max Phase: Preclinical
Molecular Formula: C18H18Cl2N4S
Molecular Weight: 356.88
Molecule Type: Small molecule
Associated Items:
ID: ALA1743929
Max Phase: Preclinical
Molecular Formula: C18H18Cl2N4S
Molecular Weight: 356.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Clc1ccc2nc(N3CCNCC3)c(Sc3ccccc3)nc2c1
Standard InChI: InChI=1S/C18H17ClN4S.ClH/c19-13-6-7-15-16(12-13)22-18(24-14-4-2-1-3-5-14)17(21-15)23-10-8-20-9-11-23;/h1-7,12,20H,8-11H2;1H
Standard InChI Key: APYWFHHZWYEMAJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 356.88 | Molecular Weight (Monoisotopic): 356.0862 | AlogP: 3.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 41.05 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.72 | CX LogP: 4.85 | CX LogD: 3.52 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.77 | Np Likeness Score: -1.54 |
1. Lumma WC, Hartman RD, Saari WS, Engelhardt EL, Lotti VJ, Stone CA.. (1981) Piperazinylquinoxalines with central serotoninmimetic activity., 24 (1): [PMID:6451700] [10.1021/jm00133a019] |
Source(1):